NNO. Muscular Genesis
3,772,348 United States Patent Office Patented Nov. 13, 1973 2 and the pharmaceutically acceptable acid addition salts 3,772,348 thereof. DERIVATIVES OF DEBENZObf)PYRROLO(3,4-d Compounds of the Formula I and the pharmaceutically AZEPINE AS CNS-DEPRESSANTS acceptable acid addition salts thereof have valuable phar Hans Blattner, Riehen, Switzerland, and Walter Schindler, deceased, late of Basel, Switzerland, by Leonhard Gysin, macological properties. They exert in particular after oral, executor, Basel, Switzerland, assignors to Ciba-Geigy rectal and parenteral administration a central depressant Corporation, Ardsley, N.Y. action on the central nervous system. For example they No Drawing. Filed May 11, 1971, Ser. No. 142,390 reduce motility, potentiate the action of anaesthetics, and Claims priority, application Switzerland, May 13, 1970, counteract the effect of amphetamine. Moreover, they 7,069/70 10 have an adrenolytic and histamineantagonistic action. Int, C. C07d 27/36 These properties are determined by selected standard tests U.S. C. 260-326.9 15 Claims (cp. R. Domenjoz and W. Theobald, Arch. Int. Pharma codyn. 120, 450 (1959), W. Theobald et al., Arzneimit ABSTRACT OF THE DISCLOSURE telforsch. 17, 561 (1967) and W. Theobald and R. Compounds of the class of 1,2,3,8-tetrahydrodibenzo 15 Domenjoz, Arzneimittelforsch. 8, 19 (1958). (b,f pyrrolo 3,4-diazepines which may be substituted in Thus, merely by illustration, it is demonstrated that 2 the 5- or 6- and/or 8-position by chlorine, the trifluoro methyl-5-chloro-1,2,3,8-tetrahydro - dibenzo[b,flpyrrolo methyl group or alkyl groups respectively or the allyl 3,4-diazepine in the form of the hydrochloride salt ef group respectively and pharmaceutically acceptable addi fects a 50%.
[Show full text]